Teva Pharmaceutical Industries (Teva Pharmaceutical Industries) Market Cap : $14,676 Mil (As of Apr. 27, 2024)

View and export this data going back to . Start your Free Trial

What is Teva Pharmaceutical Industries Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Teva Pharmaceutical Industries's share price for the quarter that ended in Dec. 2023 was $8.62. Teva Pharmaceutical Industries's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 1,121 Mil. Therefore, Teva Pharmaceutical Industries's market cap for the quarter that ended in Dec. 2023 was $9,664 Mil.

Teva Pharmaceutical Industries's quarterly market cap increased from Jun. 2023 ($7,878 Mil) to Sep. 2023 ($11,411 Mil) but then declined from Sep. 2023 ($11,411 Mil) to Dec. 2023 ($9,664 Mil).

Teva Pharmaceutical Industries's annual market cap increased from Dec. 2021 ($9,544 Mil) to Dec. 2022 ($9,931 Mil) but then declined from Dec. 2022 ($9,931 Mil) to Dec. 2023 ($9,664 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Teva Pharmaceutical Industries's Enterprise Value for Today is $31,707 Mil.

Teva Pharmaceutical Industries Market Cap Historical Data

The historical data trend for Teva Pharmaceutical Industries's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teva Pharmaceutical Industries Market Cap Chart

Teva Pharmaceutical Industries Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

9,556.66

10,307.19

9,543.80

9,931.45

9,663.80

Teva Pharmaceutical Industries Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Market Cap	Get a 7-Day Free Trial															9,931.45	8,862.44	7,878.17	11,411.47	9,663.80

Competitive Comparison of Teva Pharmaceutical Industries's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Teva Pharmaceutical Industries's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Teva Pharmaceutical Industries's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Teva Pharmaceutical Industries's Market Cap distribution charts can be found below:

* The bar in red indicates where Teva Pharmaceutical Industries's Market Cap falls into.

Teva Pharmaceutical Industries Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Teva Pharmaceutical Industries's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	$8.62	*	1121.09
	=	$9,664

Teva Pharmaceutical Industries's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )	=	Share Price (Q: Dec. 2023 )	*	Shares Outstanding (EOP) (Q: Dec. 2023 )
	=	$8.62	*	1121.09
	=	$9,664

Teva Pharmaceutical Industries (OTCPK:TEVJF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Teva Pharmaceutical Industries Market Cap Related Terms

Thank you for viewing the detailed overview of Teva Pharmaceutical Industries's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Teva Pharmaceutical Industries (Teva Pharmaceutical Industries) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teva Pharmaceutical Industries Ltd (OTCPK:TEVJF) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

TEVA:USA TEVA:Mexico TEVA:Israel 0LER:UK TEV:Germany TEV:Germany TEV:Germany T1EV34:Brazil TEVA:Austria

Address

124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020

Website

https://www.tevapharm.com

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the U.S. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a U.S.-based generic and specialty drug distributor.